Zentek Corp (ZTEK): Market Capitalization-to-Revenue Ratio

Symbol and logo of brand Zentek Limited (ZTEK)

Zentek Ltd. faces a prolonged market rollout of its graphene products and stringent FDA oversight. The company's average P/S reflects revenue valuation volatility, with the parameter stabilizing at 779.70. Business growth relies on licensing patents to third-party firms. Success is driven by leading materials scientists, who are retained through unique developments and stock options.

Price-to-Revenue Ratio: Zentek (ZTEK) for 04/28/2023 - 09/12/2026

Metric breakdowns and analytics for Zentek (ZTEK)

- stock quotes and analyst forecast:
Summary company analytics:Zentek Ltd
Mass-produced product of zentek.com

Zentek Ltd. focuses its development on the implementation of nanocoatings, which renders the company's revenue volatile during the early stages of commercialization. The P/S ratio correlates the business's market value with its actual sales volume, allowing for an assessment of the value of a single dollar of revenue. By analyzing the P/S chart, an investor can observe the dynamics of market expectations relative to sector medians. Sharp spikes in the curve signal a potential overvaluation of capitalization amid speculative optimism.

Competitors of Zentek Ltd.

Market Cap to Sales Volume ISRG|Danaher Corporation - Market Cap to Revenue|P/S Multiple Becton Dickinson & Company BDX|STE - Price-to-Revenue Ratio|West Pharmaceutical Services (WST) - Market Cap to Revenue|BAX: P/S Multiple|Market Cap to Revenue Masimo|STVN (stevanatogroup.com) - P/S Multiple|Market Cap to Revenue Ratio TFX (Teleflex Incorporated)|Price-to-Revenue Ratio Merit Medical (MMSI)|Envista - Market Cap to Revenue Ratio|ICU Medical, Inc. - Market Cap to Revenue|Market Cap to Sales Volume XRAY (Dentsply Sirona Inc)|LMAT - Price-to-Revenue Ratio|Price-to-Revenue Coefficient AtriCure Corp ATRC|staar.com (STAA) - Price-to-Revenue Ratio|Market Cap to Revenue ChromaDex Corporation|ZIMV (ZimVie Inc) - P/S Multiple|Market Cap to Revenue Ratio ANGO (AngioDynamics)|Price-to-Revenue Ratio Cerus Corp (CERS)|TKNO: Price-to-Sales Ratio|Price-to-Revenue Ratio Monogram Technologies Inc. MGRM|Market Capitalization-to-Revenue Ratio STSS|INFU - Price-to-Revenue Ratio|Market Capitalization-to-Revenue Ratio UTMD (Utah Medical Products Inc.)|KORU Medical Systems Inc. (KRMD) - Price-to-Revenue Ratio|Nyxoah S.A. - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Microbot Medical, Inc.|Market Cap to Revenue Ratio PDEX (Pro-Dex)|P/S Multiple ELUT|Milestone Scientific Inc. - Market Cap to Revenue Ratio|Price-to-Revenue Ratio NEXGEL, Inc. NXGL|Retractable Tech - Price-to-Revenue Ratio|harvardbioscience.com - P/S Multiple|FEMY (Femasys Inc.) - Market Cap to Revenue Ratio|MHUA: P/S Multiple|Predictive Oncology Corp - Market Capitalization-to-Revenue Ratio|CJMB (Callan JMB) - P/S Multiple|Price to Sales Atrion Corporation Inc. ATRI|P/S Multiple NURO